Mobile Cardiac Telemetry Systems Market Size, Share & Trends Report

Mobile Cardiac Telemetry Systems Market Size, Share & Trends Analysis Report By Application (Lead-based, Patch-based), By End Use (Hospitals, Cardiac Centers), By Region, And Segment Forecasts, 2020 - 2027

  • Published Date: Jul, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-4-68038-779-7
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018
  • Number of Pages: 120

Report Overview

The global mobile cardiac telemetry systems market size was valued at USD 675.54 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 11.3% from 2020 to 2027. Increasing prevalence of cardiovascular disorders and associated mortality has increased awareness about the benefits of Mobile Cardiac Telemetry (MCT) devices, is propelling the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2017, 800,000 deaths were reported due to cardiac disorders in the U.S., which is also the leading cause of death in the country. Furthermore, physical inactivity due to a sedentary lifestyle coupled with tobacco smoking and obesity has increased the cardiac disorder morbidities.

U.S. mobile cardiac telemetry system market size

The COVID-19 outbreak caused due to SARS-CoV-2, already affected millions of people globally as of June 2020. The contagious coronavirus is also having an economic impact and implications on most of the sectors including the medical device industry. Initially, the patients showed improvement with the combined usage of hydroxychloroquine and azithromycin but it has a risk of prolonging the QT interval. Mobile cardiac telemetry is widely used in such patients to remotely monitor them in order to reduce hospitalization.

Moreover, the device is also helpful for the rapid detection of arrhythmogenic risks for such COVID-19 patients in the outpatient setting. Hospitals are currently overburdened with patients due to the pandemic and in such cases, these devices are very helpful for remote monitoring, which is further boosting the market growth. For instance, in March 2020 Biotelemetry, Inc. expanded its mobile cardiac outpatient telemetry monitoring program to COVID-19 patients in various institutions in the U.S. to monitor QT prolongation associated with hydroxychloroquine and azithromycin medication.

The industry players are constantly trying to develop micro-sized handy devices in order to sustain their market share. For instance, in September 2019, iRhythm Technologies, Inc. collaborated with Verily Life Sciences to combine iRhythm’s AI-based system with Verily’s data analytical technology to screen, monitor, and diagnose atrial fibrillation.

Application Insights

The lead-based segment held a dominant revenue share of over 65% in the mobile cardiac telemetry systems market in 2019 because lead-based MCTs are light weighted, user-friendly, and therefore preferred among several patients. There are few disadvantages associated with lead-based MCTs such as lead failure and telemetry disruption which can limit the growth in the forthcoming years.

The patch-based segment is expected to showcase lucrative growth over the forecast period. Patch-based Continuous Cardiac Rhythm Monitoring (CCRM) has emerged in the outpatient setting as a useful clinical tool for the quantification and surveillance of bradyarrhythmia and tachyarrhythmia. These patch-based CRM devices have been studied in the outpatient setting as an alternative to traditional Holter monitoring and have emerged as feasible and patient-friendly options for the detection of clinically meaningful arrhythmia, which is fueling the demand.

End-use Insights

Hospitals segment dominated the market with a revenue share of around 60.0% in 2019. The growth can be attributed to the increased number of minimally invasive surgeries under these facilities. Moreover, hospitals are omnipresent and easily accessible, thus more preferable over other facilities. Furthermore, favorable reimbursement policies are expected to fuel the demand in the forthcoming years.

Global mobile cardiac telemetry system market share

On the basis of end-use, the market is segmented into hospitals, cardiac centers, and others. Cardiac center segment is expected to witness the fastest growth over the forecast period. The growth can be attributed to an increased number of cardiac centers and easy availability of surgeons under these facilities. The ambulatory surgical centers are also expected to gain popularity during the forecast period due to increased demand for outpatient services. Furthermore, cost-effective treatment and shorter stay duration are some factors propelling segment growth.

Regional Insights

North America dominated the market for mobile cardiac telemetry with a revenue share of around 37.0% in 2019. This growth can be attributed to various factors such as the increasing geriatric population, the prevalence of cardiac disorders, and rising healthcare expenditure. For instance, according to the report published by the Administration for Community Living, there has been a 33% increase in the geriatric population in the U.S. in the past decade. Moreover, the presence of major service providers with improved healthcare solutions is expected to fuel market growth during the forecast period.

Asia Pacific is expected to exhibit lucrative growth over the forecast period. Factors such as dietary habits and rising adoption of a sedentary lifestyle leading to physical inactivity are contributing to the increased cardiovascular morbidities in the region. According to the Ministry of Health Labor and Welfare, around 170,000 deaths were attributed to cardiovascular diseases each year in Japan. Moreover, several multinational companies are setting up their manufacturing business in the region due to low manufacturing costs and skilled labor. The aforementioned factors are further fueling the demand for mobile cardiac telemetry devices.

Key Companies & Market Share Insights

The market is competitive in nature. Some of the major industry players are involved in strategic collaborations, regional expansions, and new product launches to increase their market penetration. For instance, in March 2018, Biotricity Inc. launched ‘Bioflux’ which is a cardiac telemetry solution for precise and real-time monitoring. Additionally, in February 2019, Preventice Solutions and GE Healthcare collaborated to offer MUSE integrated single-vendor solutions to provide seamless workflow. In July 2019, Biotelemetry acquired ADEA Medical AB. This acquisition is aligned with BioTelemetry’s longer-term strategy to expand its international business in the Nordics and other European countries. Some of the prominent players in the mobile cardiac telemetry systems market include:

  • BioTelemetry, Inc.

  • ScottCare

  • Biotricity Inc.

  • Welch Allyn

  • Applied Cardiac Systems Inc.

  • Medicomp Inc.

  • Preventice Solutions

  • Telerhythmics LLC

  • Zoll Medical Corporation

  • iRhythm Technologies, Inc.

Mobile Cardiac Telemetry Systems Market Report Scope

Report Attribute

Details

Market size value in 2020

USD 749.85 million

Revenue forecast in 2027

USD 1.58 billion

Growth Rate

CAGR of 11.3% from 2020 to 2027

Base year for estimation

2019

Historical data

2016 - 2018

Forecast period

2020 - 2027

Quantitative units

Revenue in USD Million and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; Germany; U.K.; France; Italy; Spain; Japan; China; India; Australia; Brazil; Mexico; South Africa; Saudi Arabia

Key companies profiled

BioTelemetry Inc.; ScottCare; Biotricity Inc.; Welch Allyn; Applied Cardiac Systems Inc.; Medicomp Inc.; Preventice Solutions; Telerhythmics LLC; iRhythm Technologies, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country-level and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global mobile cardiac telemetry systems market report on the basis of application, end use, and region:

  • Application Outlook (Revenue, USD Million, 2016 - 2027)

    • Lead-based

    • Patch-based

  • End-use Outlook (Revenue, USD Million. 2016 - 2027)

    • Hospitals

    • Cardiac centers

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2027)

    • North America

      • U.S.

      • Canada

    • Europe

      • The U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

Pricing & Purchase Options

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified